By Niall Ferguson (original source Prospect)
“Is big tech too big? In the past year, interest has grown in the idea that the giants of Silicon Valley have morphed into monopolies. Tim Wu of Columbia Law School argues they should be broken up: Facebook should relinquish Instagram and WhatsApp; Google should give up YouTube and DoubleClick; Amazon should spin off Amazon Web Services. Such arguments have ceased to be the preserve of progressives. Even President Donald Trump is said to have “wondered aloud if there may be any way to go after Amazon with antitrust or competition law.”
We’ll hear a lot more about breaking up big tech in 2019. However, there are significant problems with anti-trust law that we would do well to note. History tells us that enforcing competition against big concentrations of capital is harder than it looks. The analogy with John D Rockefeller’s Standard Oil is often drawn (I’ve heard Google referred to as “Standard Data”). Antitrust law was developed in the US over a century ago, as a response to the rise of trusts and combinations—that is, cross-ownership and management structures facilitating collusion. At first, Standard Oil had been praised for bringing down the price of kerosene. However, in the early 1900s, journalists helped turn public opinion against Rockefeller. Supreme Court Justice Louis Brandeis coined the phrase “the curse of bigness,” arguing that firms could be too big to treat employees on equal terms, to be efficient, and to treat rivals fairly. A landmark 1911 judgment broke Standard Oil up into no less than 34 separate firms.”
Click here to read more
Dr. Scott Gottlieb on the impact of Pres. Trump’s policies on Big Pharma and R&D
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Squawk Box’ to discuss the impact of President Trump’s tariff policy and executive order on the pharmaceutical industry,…
Thought Leader: Scott Gottlieb
Marc Short on Trump’s Relationship with Saudi Arabia
How has Trump’s approach to U.S.-Saudi relations shaped American foreign policy, and what are the potential risks and rewards for the U.S. economy and regional…
Thought Leader: Marc Short
Dr. Deborah Birx: Trump is protecting national security of our medicine
On Tuesday’s “American Agenda,” Dr. Deborah Birx spoke about President Trump’s push to cut prescription drug prices. Dr. Deborah Birx is a world-renowned physician,…
Thought Leader: Deborah Birx
